Healius (ASX:HLS) entered a binding agreement to sell its Lumus Imaging subsidiary to funds managed by Affinity Equity Partners in a deal that values the business at AU$965 million, according to a Monday filing with the Australian bourse.
The sale is expected to reap AU$835 million in proceeds after repayment of equipment leases and more than AU$800 million after transaction fees, separation costs, and other fees, the filing stated.
The deal is expected to close in Q1 2025, subject to Foreign Investment Review Board approval, according to the filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.